Dolutegravir: First Global Approval-Reference-Cited by-同舟云学术

Dolutegravir: First Global Approval

Published:2013-09 Issue:14 Volume:73 Page:1627-1637
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Ballantyne Anita D.,Perry Caroline M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-013-0121-4.pdf

Reference62 articles.

1. Messiaen P, Wensing AMJ, Fun A, et al. Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis. PLoS ONE [Electronic Resource]. 2013;8(1):e52562.

2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf . Accessed 23 Aug 2013.

3. Mesplede T, Quashie PK, Wainberg MA. Resistance to HIV integrase inhibitors. Curr Opin HIV AIDS. 2012;7(5):401–8.

4. Abram ME, Hluhanich RM, Goodman DD, et al. Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. Antimicrob Agents Chemother. 2013;57(6):2654–63.

5. Powderly WG. Integrase inhibitors in the treatment of HIV-1 infection. J Antimicrob Chemother. 2010;65(12):2485–8.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dolutegravir and the management of HIV/AIDS in the South African adult population;SA Pharmaceutical Journal;2024-04

2. A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies;Statistics in Medicine;2023-12

3. Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage;Bioorganic Chemistry;2023-12

4. Pd-catalyzed Stereodivergent [4+2] Annulation to Access [6.7]-Fused N-Heterocycles;Synlett;2023-09-29

5. The effect of ARVs on the MEKKK1 gene promoter, inflammatory cytokine expression and signalling in acute treated Jurkat T cells;Xenobiotica;2022-12-02